BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38182727)

  • 21. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein barr virus IgG and EBER-1 in Burkitt's lymphoma children at a referral hospital in western Kenya.
    Ndede I; Mining SK; Patel K; Wanjala FM; Tenge CN
    Pan Afr Med J; 2019; 34():206. PubMed ID: 32180880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigens and genetic susceptibility to lymphoma.
    McAulay KA; Jarrett RF
    Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.
    Engdahl E; Gustafsson R; Huang J; Biström M; Lima Bomfim I; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A
    Front Immunol; 2019; 10():2715. PubMed ID: 32038605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.
    Grande BM; Gerhard DS; Jiang A; Griner NB; Abramson JS; Alexander TB; Allen H; Ayers LW; Bethony JM; Bhatia K; Bowen J; Casper C; Choi JK; Culibrk L; Davidsen TM; Dyer MA; Gastier-Foster JM; Gesuwan P; Greiner TC; Gross TG; Hanf B; Harris NL; He Y; Irvin JD; Jaffe ES; Jones SJM; Kerchan P; Knoetze N; Leal FE; Lichtenberg TM; Ma Y; Martin JP; Martin MR; Mbulaiteye SM; Mullighan CG; Mungall AJ; Namirembe C; Novik K; Noy A; Ogwang MD; Omoding A; Orem J; Reynolds SJ; Rushton CK; Sandlund JT; Schmitz R; Taylor C; Wilson WH; Wright GW; Zhao EY; Marra MA; Morin RD; Staudt LM
    Blood; 2019 Mar; 133(12):1313-1324. PubMed ID: 30617194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China.
    Liu W; Li WM; Sun NL
    Ann Hum Genet; 2005 Jul; 69(Pt 4):382-8. PubMed ID: 15996167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.
    Kelly GL; Stylianou J; Rasaiyaah J; Wei W; Thomas W; Croom-Carter D; Kohler C; Spang R; Woodman C; Kellam P; Rickinson AB; Bell AI
    J Virol; 2013 Mar; 87(5):2882-94. PubMed ID: 23269792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies.
    Saikumar Lakshmi P; Oduor CI; Forconi CS; M'Bana V; Bly C; Gerstein RM; Otieno JA; Ong'echa JM; Münz C; Luftig MA; Brehm MA; Bailey JA; Moormann AM
    Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36878637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
    Khdair SI; Jarrar W; Jarrar YB; Bataineh S; Al-Khaldi O
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):895-902. PubMed ID: 31742498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.
    Khanna R; Burrows SR; Thomson SA; Moss DJ; Cresswell P; Poulsen LM; Cooper L
    J Immunol; 1997 Apr; 158(8):3619-25. PubMed ID: 9103423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Parkinson disease with structural and regulatory variants in the HLA region.
    Wissemann WT; Hill-Burns EM; Zabetian CP; Factor SA; Patsopoulos N; Hoglund B; Holcomb C; Donahue RJ; Thomson G; Erlich H; Payami H
    Am J Hum Genet; 2013 Nov; 93(5):984-93. PubMed ID: 24183452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma.
    Xu L; Zhang M; Tu D; Lu Z; Lu T; Ma D; Zhou Y; Zhang S; Ma Y; Yan D; Wang X; Sang W
    J Pharmacol Exp Ther; 2023 Dec; 387(3):288-298. PubMed ID: 37875309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.
    Simbiri KO; Smith NA; Otieno R; Wohlford EE; Daud II; Odada SP; Middleton F; Rochford R
    PLoS One; 2015; 10(5):e0125420. PubMed ID: 25933165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.
    Kutszegi N; Yang X; Gézsi A; Schermann G; Erdélyi DJ; Semsei ÁF; Gábor KM; Sági JC; Kovács GT; Falus A; Zhang H; Szalai C
    Haematologica; 2017 Sep; 102(9):1578-1586. PubMed ID: 28596278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya.
    Redmond LS; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Masalu N; Kawira E; Otim I; Legason ID; Dhudha H; Ayers LW; Bhatia K; Goedert JJ; Mbulaiteye SM
    Malar J; 2020 Jul; 19(1):239. PubMed ID: 32718346
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Jia Y; Su T; Gu Y; Li C; Zhou X; Su J; Sun P; Tang J; Yang L; Liu G; Yang L
    J Immunol; 2018 Jul; 201(2):423-431. PubMed ID: 29858267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
    Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
    Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.